Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcome. (Q53671283)
Jump to navigation
Jump to search
scientific article published in April 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcome. |
scientific article published in April 2002 |
Statements
Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcome. (English)
Southwest Oncology Group
1 reference
Vernon K Sondak
Jeffrey A Sosman
Joseph M Unger
P-Y Liu
Lawrence E Flaherty
Min S Park
Raymond A Kempf
John A Thompson
Paul I Terasaki
1 April 2002
20
8
2067-2075